News Releases

July 21, 2021

Indivior to Announce Q2/H1 2021 Results and Host a Presentation on July 29th

June 30, 2021

Indivior Raises FY 2021 Guidance

June 24, 2021

Indivior Presents New Data at the College on Problems of Drug Dependence (CPDD) 2021 Annual Conference

June 8, 2021

Indivior Extends Leadership Position in Substance Use Disorder Treatment with Exclusive Agreement for Leading Asset Targeting Cannabis-Related Disorders.

April 30, 2021

Indivior Applauds Biden Administration’s New Buprenorphine Practice Guidelines

April 29, 2021

Indivior Announces Q1 2021 Financial Results

April 28, 2021

Indivior Statement Regarding State Attorney General’s Recent Announcements Relating to SUBOXONE® (buprenorphine and naloxone) Film Settlements

April 22, 2021

Study Examining Impact of COVID-19 Pandemic on Opioid Use Disorder (OUD) Finds Greater Barriers to Care During Pandemic

April 22, 2021

Indivior Welcomes White House Announcement Prioritizing Expanded Access to Evidence-Based Treatment

March 24, 2021

Board Appointments and Succession Plan Announced